These findings are very robust and compelling, says Jorge Moreno, MD, assistant professor and obesity medicine doctor at Yale Medicine in New Haven, Connecticut, who was not involved in the study
Optometrists should advise their patients that although these medications are conclusively linked to an increased risk of NAION, the overall risk is still extremely low: only about 2.30 per 100,000 people are diagnosed with NAION each year
This often involves documenting the patients health conditions, failed attempts at weight loss, and the potential benefits of the surgery
Dont tough it out, tell your doctor early so we can adjust the plan and keep you on track
By activating both pathways simultaneously, tirzepatide supports weight loss through coordinated metabolic signaling rather than appetite suppression alone
Do not use on damaged skin